lilly self pay tirzepatide Eli has launched new self-pay options for tirzepatide, introducing 7.5 mg and 10 mg single-dose vials for $499 through the Zepbound Journey Program. This initiative, available exclusively via LillyDirect Eli Lilly is now offering

Patients should contact their insurance plan to verify coverage details, including tier placement, prior authorization requirements, and out-of-pocket costs before filling prescriptions

Understanding Lipotropic Injections: What Are They

After 36 weeks of tirzepatide-induced weight loss (mean 20.9%), participants randomized to placebo regained a mean of 14.8% of body weight over 52 weeks

LifeScan Utilization Management and Formulary Deletion Product Removal & UM Changes : Due to LifeScans Chapter 11 bankruptcy, OneTouch diabetic test strips and meters will be removed from Highmarks Commercial and Exchange formularies starting September 15, 2025